Corroborating the prognostic value of EpCAM-positive CTCs in other recent series [14,15], the detection of CTCs in the HCC cohort of this study was significantly associated with high AFP and the presence of vascular invasion, and there was a non-significant trend toward poorer overall survival in patients with detectable CTCs. This evidence concerns the gene EPCAM and hepatocellular carcinoma.